Search

everythinglearnresearchcommunity

for

Search:↓

DM and AA may share a common cause.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

Applying latanoprost on skin can stimulate hair growth with minimal side effects.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

A patient developed a blister at the injection site after hepatitis C treatment.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.